# Expansion of Virus-Specific Lymphocytes for Cell Therapy

> **NCT06011486** · PHASE1 · RECRUITING · sponsor: **Hospital Israelita Albert Einstein** · enrollment: 10 (estimated)

## Conditions studied

- CMV Viremia
- CMV

## Interventions

- **COMBINATION_PRODUCT:** Lymphocyte infusion (ImmuneCellVir-I)

## Key facts

- **NCT ID:** NCT06011486
- **Lead sponsor:** Hospital Israelita Albert Einstein
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-10
- **Primary completion:** 2025-06-10
- **Final completion:** 2026-06-10
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06011486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06011486, "Expansion of Virus-Specific Lymphocytes for Cell Therapy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06011486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*